These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 30939760)

  • 1. Drop-On-Powder 3D Printing of Tablets with an Anti-Cancer Drug, 5-Fluorouracil.
    Shi K; Tan DK; Nokhodchi A; Maniruzzaman M
    Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 30939760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Powder bed 3D-printing of highly loaded drug delivery devices with hydroxypropyl cellulose as solid binder.
    Infanger S; Haemmerli A; Iliev S; Baier A; Stoyanov E; Quodbach J
    Int J Pharm; 2019 Jan; 555():198-206. PubMed ID: 30458260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
    Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
    Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing.
    Skowyra J; Pietrzak K; Alhnan MA
    Eur J Pharm Sci; 2015 Feb; 68():11-7. PubMed ID: 25460545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
    Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coupling of Fused Deposition Modeling and Inkjet Printing to Produce Drug Loaded 3D Printed Tablets.
    Junqueira LA; Tabriz AG; Raposo FJ; Carobini LR; Vaz UP; Brandão MAF; Douroumis D; Raposo NRB
    Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets.
    Goyanes A; Buanz AB; Hatton GB; Gaisford S; Basit AW
    Eur J Pharm Biopharm; 2015 Jan; 89():157-62. PubMed ID: 25497178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D printing of high drug loaded dosage forms using thermoplastic polyurethanes.
    Verstraete G; Samaro A; Grymonpré W; Vanhoorne V; Van Snick B; Boone MN; Hellemans T; Van Hoorebeke L; Remon JP; Vervaet C
    Int J Pharm; 2018 Jan; 536(1):318-325. PubMed ID: 29217471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
    Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
    Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
    Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
    J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making tablets for delivery of poorly soluble drugs using photoinitiated 3D inkjet printing.
    Clark EA; Alexander MR; Irvine DJ; Roberts CJ; Wallace MJ; Yoo J; Wildman RD
    Int J Pharm; 2020 Mar; 578():118805. PubMed ID: 31715351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D printed oral theophylline doses with innovative 'radiator-like' design: Impact of polyethylene oxide (PEO) molecular weight.
    Isreb A; Baj K; Wojsz M; Isreb M; Peak M; Alhnan MA
    Int J Pharm; 2019 Jun; 564():98-105. PubMed ID: 30974194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drop-on-powder 3D printing of amorphous high dose oral dosage forms: Process development, opportunities and printing limitations.
    Gottschalk N; Burkard A; Quodbach J; Bogdahn M
    Int J Pharm X; 2023 Dec; 5():100151. PubMed ID: 36687376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
    Alhijjaj M; Belton P; Qi S
    Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fused-filament 3D printing (3DP) for fabrication of tablets.
    Goyanes A; Buanz AB; Basit AW; Gaisford S
    Int J Pharm; 2014 Dec; 476(1-2):88-92. PubMed ID: 25275937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the influence of solvent composition on Drop-on-Demand binder jet 3D printed tablets containing calcium sulfate hemihydrate.
    Lu A; Duggal I; Daihom BA; Zhang Y; Maniruzzaman M
    Int J Pharm; 2024 Jan; 649():123652. PubMed ID: 38040397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Track-and-trace: Novel anti-counterfeit measures for 3D printed personalized drug products using smart material inks.
    Trenfield SJ; Xian Tan H; Awad A; Buanz A; Gaisford S; Basit AW; Goyanes A
    Int J Pharm; 2019 Aug; 567():118443. PubMed ID: 31212052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing.
    Gültekin HE; Tort S; Acartürk F
    Pharm Res; 2019 Jun; 36(9):128. PubMed ID: 31250313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct cyclodextrin-based powder extrusion 3D printing for one-step production of the BCS class II model drug niclosamide.
    Pistone M; Racaniello GF; Arduino I; Laquintana V; Lopalco A; Cutrignelli A; Rizzi R; Franco M; Lopedota A; Denora N
    Drug Deliv Transl Res; 2022 Aug; 12(8):1895-1910. PubMed ID: 35138629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Incorporation into Polymer Filament Using Simple Soaking Method for Tablet Preparation Using Fused Deposition Modeling.
    Tagami T; Kuwata E; Sakai N; Ozeki T
    Biol Pharm Bull; 2019; 42(10):1753-1760. PubMed ID: 31582663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.